コンテンツへスキップ
Merck
  • Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6.

Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6.

Scientific reports (2018-10-31)
Marta De Donato, Benedetta Righino, Flavia Filippetti, Alessandra Battaglia, Marco Petrillo, Davide Pirolli, Giovanni Scambia, Maria Cristina De Rosa, Daniela Gallo
要旨

The NIMA (never in mitosis, gene A)-related kinase-6 (NEK6), which is implicated in cell cycle control and plays significant roles in tumorigenesis, is an attractive target for the development of novel anti-cancer drugs. Here we describe the discovery of a potent ATP site-directed inhibitor of NEK6 identified by virtual screening, adopting both structure- and ligand-based techniques. Using a homology-built model of NEK6 as well as the pharmacophoric features of known NEK6 inhibitors we identified novel binding scaffolds. Twenty-five compounds from the top ranking hits were subjected to in vitro kinase assays. The best compound, i.e. compound 8 ((5Z)-2-hydroxy-4-methyl-6-oxo-5-[(5-phenylfuran-2-yl)methylidene]-5,6-dihydropyridine-3-carbonitrile), was able to inhibit NEK6 with low micromolar IC50 value, also displaying antiproliferative activity against a panel of human cancer cell lines. Our results suggest that the identified inhibitor can be used as lead candidate for the development of novel anti-cancer agents, thus opening the possibility of new therapeutic strategies.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
アデノシン 5'-三リン酸 二ナトリウム塩 水和物, Grade I, ≥99%, from microbial
カタログ番号
容量
在庫状況
単価
数量
Sigma-Aldrich
モノクロナール抗β-アクチン マウス宿主抗体, clone AC-15, ascites fluid
ログイン組織・契約価格を表示する
カタログ番号容量在庫状況単価数量
0.2 mL
1 出荷可能日 2025年1月06日
詳細...
お客様のターゲット用に防腐剤フリーのリコンビナント抗体を利用できます。ZRB1312をお試しください
¥98,300
100 μL
1 出荷可能日 2025年1月06日
詳細...
お客様のターゲット用に防腐剤フリーのリコンビナント抗体を利用できます。ZRB1312をお試しください
¥98,300
0.5 mL
1 出荷可能日 2025年1月06日
詳細...
お客様のターゲット用に防腐剤フリーのリコンビナント抗体を利用できます。ZRB1312をお試しください
¥195,000